Nanomedicine is a branch of medicine using nanotechnology to prevent and treat diseases.
Nanotechnology represents one of the most effective approaches in elevating a drug's …

Combining existing drug therapy is essential in developing new therapeutic agents in
disease prevention and treatment. In preclinical investigations, combined effect of certain …

The liposome is the first nanomedicine transformed into the market and applied to human
patients. Since then, such phospholipid bilayer vesicles have undergone technological …

Due to stimulation by invading endogenous signals or pathogens such as injured cells,
inflammation may result in tissue healing or, if left uncontrolled, may cause disease …

Hypoxic pulmonary hypertension (HPH) is characterized by pulmonary vascular sustained
constriction and progressive remodeling, which are initiated by hypoxia then with hypoxia …

Local delivery of nanomedicines holds therapeutic promise for colorectal cancer (CRC).
However, it presents tremendous challenges due to the existence of multiple physiological …

Carrier-free nanodrugs with extraordinary active pharmaceutical ingredient (API) loading
(even 100%), avoidable carrier-induced toxicity, and simple synthetic procedures are …

Growing evidence indicates that hyperinflammatory syndrome and cytokine storm observed
in COVID-19 severe cases are narrowly associated with the disease's poor prognosis …

Pulmonary hypertension (PH) is a chronic and fatal disease, for which new therapeutic
drugs and approaches are needed urgently. Baicalein and baicalin, the active compounds …

Highlights•Nanomedicine has emerged as a field with great opportunities to improve
treatment strategies.•Pulmonary arterial hypertension (PAH) is a serious and incurable …